View on Pubmed.gov 32337254 | View on doi.org 10.1155/2020/50...
Protein Phosphorylation in Serine Residues Correlates with Progression from Precancerous Lesions to Cervical Cancer in Mexican Patients.
- Departamento de Infectómica y Patogénesis Molecular, Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN), Ciudad de México 07360, Mexico.
- Universidad Autónoma de la Ciudad de México (UACM), Plantel Cuautepec, Ciudad de México 07160, Mexico.
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional (ESM-IPN), Ciudad de México 11340, Mexico.
- Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México (UACM), Plantel del Valle, Ciudad de México 03100, Mexico.
- Unidad de Estudios Superiores de Tultitlan, Universidad Mexiquense del Bicentenario, Estado de México 54910, Mexico.
- Unidad Multidisciplinaria de Investigación Experimental (UMIEZ), Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México (UNAM), Ciudad de México 09230, Mexico.
- Clínica de Displasias y Anatomía Patológica, Hospital Juárez de México, Ciudad de México 07760, Mexico.
- Laboratorio de Bioquímica Farmacológica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (ENCB-IPN), Ciudad de México 11340, Mexico.
Abstract
Protein phosphorylation is a posttranslational modification that is essential for normal cellular processes; however, abnormal phosphorylation is one of the prime causes for alteration of many structural, functional, and regulatory proteins in disease conditions. In cancer, changes in the states of protein phosphorylation in tyrosine residues have been more studied than phosphorylation in threonine or serine residues, which also undergo alterations with greater predominance. In general, serine phosphorylation leads to the formation of multimolecular signaling complexes that regulate diverse biological processes, but in pathological conditions such as tumorigenesis, anomalous phosphorylation may result in the deregulation of some signaling pathways. Cervical cancer (CC), the main neoplasm associated with human papillomavirus (HPV) infection, is the fourth most frequent cancer worldwide. Persistent infection of the cervix with high-risk human papillomaviruses produces precancerous lesions starting with low-grade squamous intraepithelial lesions (LSIL), progressing to high-grade squamous intraepithelial lesions (HSIL) until CC is generated. Here, we compared the proteomic profile of phosphorylated proteins in serine residues from healthy, LSIL, HSIL, and CC samples. Our data show an increase in the number of phosphorylated proteins in serine residues as the grade of injury rises. These results provide a support for future studies focused on phosphorylated proteins and their possible correlation with the progression of cervical lesions.
References
Int J Mol Sci. 2016 Jan 21;17(1):
Eur J Biochem. 2001 Oct;268(19):5001-10
Trends Biochem Sci. 2006 Jul;31(7):383-94
World J Gastroenterol. 2005 Jun 7;11(21):3285-9
Cited by 7 citations (total)
Journal Article
Analysis of HPV Integrations in Mexican Pre-Tumoral Cervical Lesions Reveal Centromere-Enriched Breakpoints and Abundant Unspecific HPV Regions.
Electronic publication date May 1, 2021
María Lourdes Garza-Rodríguez [...] Víctor Treviño et al.
Human papillomavirus (HPV) DNA integration is a crucial event in cervical carcinogenesis. However, scarce studies have focused on studying HPV...
Journal Article Review
Regulation of the Human Papillomavirus Lifecyle through Post-Translational Modifications of the Viral E2 Protein.
Electronic publication date July 3, 2021
Leny Jose [...] Marsha DeSmet et al.
The human papillomavirus (HPV) is a DNA tumor virus that infects cutaneous and mucosal epithelia where high-risk (HR) HPV infections...
Conflict of interest statement
The authors have declared no conflict of interest.
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
Substances
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
Copyright
Copyright © 2020 Juan Ramón Padilla-Mendoza et al.